Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1985-10-21
|
pubmed:abstractText |
Our study compares the properties of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase from a human metastatic virilizing carcinoma and that from normal adrenal glands obtained from kidney donors. Optimal conditions for enzyme assay were obtained when a 50-mM imidazole buffer (pH 7.2) containing 5 mM EDTA, 250 mM NaCl, 1 mM phenyl-methylsulfonylfluoride, 0.1 mM leupeptin, and 5.5 mM dithiothreitol (DTT) was used. A 30-min preincubation period preceding addition of substrates enhanced reductase activity by 1.75-fold. In crude microsomal preparations, Km values were similar for both tumor and normal tissues and varied between 4 and 5 microM (S)HMG-CoA. The presence of NaF in homogenization and incubation media decreased the maximum velocity, but not the Km. A partially purified rat liver phosphorylase phosphatase preparation or a similar preparation from the carcinoma restored to maximal levels the reductase activity of microsomes prepared in the presence of NaF. A Km of 96 microM NADP was found for the carcinoma microsomal preparation. Preincubation of microsomes in the presence of monothioglycerol or DTT resulted in an increased reductase activity, suggesting a possible inactive enzyme precursor(s) consisting of disulfide-linked units. Reactions of the DTT-activated enzyme incubated in the presence of increasing amounts of NADPH showed sigmoidal kinetics. Under reducing conditions, sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting revealed the presence of a 92.5K mol wt protein band that reacted with a rat antireductase antibody. Reductase activity in different regions of the carcinoma varied from 679-1763 pmol/mg protein, with an average of 1146 pmol. In three normal adrenal glands we found values of 23.4, 48.1, and 36 pmol. We concluded that the expression of HMG-CoA reductase activity was elevated in human adrenal carcinoma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Dithiothreitol,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl CoA Reductases,
http://linkedlifedata.com/resource/pubmed/chemical/NADP,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphorylase Phosphatase,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium Fluoride
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0013-7227
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
117
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1462-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3896758-Adrenal Cortex,
pubmed-meshheading:3896758-Adrenal Gland Neoplasms,
pubmed-meshheading:3896758-Adrenal Glands,
pubmed-meshheading:3896758-Cholesterol,
pubmed-meshheading:3896758-Dithiothreitol,
pubmed-meshheading:3896758-Dose-Response Relationship, Drug,
pubmed-meshheading:3896758-Female,
pubmed-meshheading:3896758-Humans,
pubmed-meshheading:3896758-Hydroxymethylglutaryl CoA Reductases,
pubmed-meshheading:3896758-Immunosorbent Techniques,
pubmed-meshheading:3896758-Kinetics,
pubmed-meshheading:3896758-Male,
pubmed-meshheading:3896758-Middle Aged,
pubmed-meshheading:3896758-NADP,
pubmed-meshheading:3896758-Phosphorylase Phosphatase,
pubmed-meshheading:3896758-Sodium Fluoride
|
pubmed:year |
1985
|
pubmed:articleTitle |
Characterization of 3-hydroxy-3-methylglutaryl coenzyme A reductase in human adrenal cortex.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|